186 related articles for article (PubMed ID: 30045664)
1. CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner.
Prevo R; Pirovano G; Puliyadi R; Herbert KJ; Rodriguez-Berriguete G; O'Docherty A; Greaves W; McKenna WG; Higgins GS
Cell Cycle; 2018; 17(12):1513-1523. PubMed ID: 30045664
[TBL] [Abstract][Full Text] [Related]
2. CDK1 inhibitor controls G2/M phase transition and reverses DNA damage sensitivity.
Sunada S; Saito H; Zhang D; Xu Z; Miki Y
Biochem Biophys Res Commun; 2021 Apr; 550():56-61. PubMed ID: 33684621
[TBL] [Abstract][Full Text] [Related]
3. The synthesized 2-(2-fluorophenyl)-6,7-methylenedioxyquinolin-4-one (CHM-1) promoted G2/M arrest through inhibition of CDK1 and induced apoptosis through the mitochondrial-dependent pathway in CT-26 murine colorectal adenocarcinoma cells.
Chou LC; Yang JS; Huang LJ; Wu HC; Lu CC; Chiang JH; Chen KT; Kuo SC; Chung JG
J Gastroenterol; 2009; 44(10):1055-63. PubMed ID: 19688288
[TBL] [Abstract][Full Text] [Related]
4. Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells.
Xiao D; Johnson CS; Trump DL; Singh SV
Mol Cancer Ther; 2004 May; 3(5):567-75. PubMed ID: 15141014
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cdk1 by alsterpaullone and thioflavopiridol correlates with increased transit time from mid G2 through prophase.
Soni DV; Jacobberger JW
Cell Cycle; 2004 Mar; 3(3):349-57. PubMed ID: 14726692
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle synchronization at the G2/M phase border by reversible inhibition of CDK1.
Vassilev LT
Cell Cycle; 2006 Nov; 5(22):2555-6. PubMed ID: 17172841
[TBL] [Abstract][Full Text] [Related]
7. Cdk5 activator-binding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint.
Jiang H; Luo S; Li H
J Biol Chem; 2005 May; 280(21):20651-9. PubMed ID: 15790566
[TBL] [Abstract][Full Text] [Related]
8. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
Wang Q; Fan S; Eastman A; Worland PJ; Sausville EA; O'Connor PM
J Natl Cancer Inst; 1996 Jul; 88(14):956-65. PubMed ID: 8667426
[TBL] [Abstract][Full Text] [Related]
9. Wee1 Kinase Inhibitor AZD1775 Effectively Sensitizes Esophageal Cancer to Radiotherapy.
Yang L; Shen C; Pettit CJ; Li T; Hu AJ; Miller ED; Zhang J; Lin SH; Williams TM
Clin Cancer Res; 2020 Jul; 26(14):3740-3750. PubMed ID: 32220892
[TBL] [Abstract][Full Text] [Related]
10. The novel synthesized 2-(3-(methylamino)phenyl)-6-(pyrrolidin-1-yl)quinolin-4-one (Smh-3) compound induces G2/M phase arrest and mitochondrial-dependent apoptotic cell death through inhibition of CDK1 and AKT activity in HL-60 human leukemia cells.
Huang SM; Yang JS; Tsai SC; Chen MH; Hsu MH; Lin HY; Chou LC; Chinag JH; Lee KH; Huang LJ; Kuo SC
Int J Oncol; 2011 May; 38(5):1357-64. PubMed ID: 21344160
[TBL] [Abstract][Full Text] [Related]
11. AZD5438, an inhibitor of Cdk1, 2, and 9, enhances the radiosensitivity of non-small cell lung carcinoma cells.
Raghavan P; Tumati V; Yu L; Chan N; Tomimatsu N; Burma S; Bristow RG; Saha D
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e507-14. PubMed ID: 22795803
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of mixed lineage kinase MLK3 by cyclin-dependent kinases CDK1 and CDK2 controls ovarian cancer cell division.
Cedeno-Rosario L; Honda D; Sunderland AM; Lewandowski MD; Taylor WR; Chadee DN
J Biol Chem; 2022 Aug; 298(8):102263. PubMed ID: 35843311
[TBL] [Abstract][Full Text] [Related]
13. Increased G2 chromosomal radiosensitivity in cancer patients: the role of cdk1/cyclin-B activity level in the mechanisms involved.
Terzoudi GI; Jung T; Hain J; Vrouvas J; Margaritis K; Donta-Bakoyianni C; Makropoulos V; Angelakis P; Pantelias GE
Int J Radiat Biol; 2000 May; 76(5):607-15. PubMed ID: 10866282
[TBL] [Abstract][Full Text] [Related]
14. The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe.
Castedo M; Perfettini JL; Roumier T; Yakushijin K; Horne D; Medema R; Kroemer G
Oncogene; 2004 May; 23(25):4353-61. PubMed ID: 15048074
[TBL] [Abstract][Full Text] [Related]
15. Targeted radiosensitization by the Chk1 inhibitor SAR-020106.
Borst GR; McLaughlin M; Kyula JN; Neijenhuis S; Khan A; Good J; Zaidi S; Powell NG; Meier P; Collins I; Garrett MD; Verheij M; Harrington KJ
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1110-8. PubMed ID: 22981708
[TBL] [Abstract][Full Text] [Related]
16. Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.
Kang J; Sergio CM; Sutherland RL; Musgrove EA
BMC Cancer; 2014 Jan; 14():32. PubMed ID: 24444383
[TBL] [Abstract][Full Text] [Related]
17. Diallyl trisulfide-induced G2/M phase cell cycle arrest in DU145 cells is associated with delayed nuclear translocation of cyclin-dependent kinase 1.
Herman-Antosiewicz A; Kim YA; Kim SH; Xiao D; Singh SV
Pharm Res; 2010 Jun; 27(6):1072-9. PubMed ID: 20143254
[TBL] [Abstract][Full Text] [Related]
18. Isoalantolactone Enhances the Radiosensitivity of UMSCC-10A Cells via Specific Inhibition of Erk1/2 Phosphorylation.
Fan Y; Weng Z; Gao H; Hu J; Wang H; Li L; Liu H
PLoS One; 2015; 10(12):e0145790. PubMed ID: 26716456
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol analogue (E)-8-acetoxy-2-[2-(3,4-diacetoxyphenyl)ethenyl]-quinazoline induces G₂/M cell cycle arrest through the activation of ATM/ATR in human cervical carcinoma HeLa cells.
Kim JY; Choi HE; Lee HH; Shin JS; Shin DH; Choi JH; Lee YS; Lee KT
Oncol Rep; 2015 May; 33(5):2639-47. PubMed ID: 25812484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
